Innovator IBD 50 ETF (NYSEARCA:FFTY) Short Interest Update

Innovator IBD 50 ETF (NYSEARCA:FFTY) saw a significant growth in short interest in the month of April. As of April 30th, there was short interest totaling 28,287 shares, a growth of 259.9% from the April 15th total of 7,859 shares. Based on an average trading volume of 46,996 shares, the days-to-cover ratio is currently 0.6 days. Currently, 1.2% of the company’s shares are sold short.

Hedge Funds Weigh In On Innovator IBD 50 ETF

Hedge funds and other institutional investors have recently made changes to their positions in the company. AlphaCore Capital LLC bought a new position in shares of Innovator IBD 50 ETF during the 4th quarter worth $32,000. International Assets Investment Management LLC bought a new stake in Innovator IBD 50 ETF during the fourth quarter valued at about $35,000. Advisory Services Network LLC bought a new stake in Innovator IBD 50 ETF during the third quarter valued at about $43,000. Simplex Trading LLC bought a new stake in Innovator IBD 50 ETF during the fourth quarter valued at about $41,000. Finally, Kestra Advisory Services LLC bought a new stake in Innovator IBD 50 ETF during the fourth quarter valued at about $72,000.

Innovator IBD 50 ETF Stock Performance

FFTY stock traded down $1.53 on Friday, reaching $40.63. The company’s stock had a trading volume of 42,779 shares, compared to its average volume of 80,227. Innovator IBD 50 ETF has a 12-month low of $28.64 and a 12-month high of $42.30. The business has a fifty day simple moving average of $36.80 and a two-hundred day simple moving average of $36.85. The firm has a market cap of $93.45 million, a PE ratio of 30.34 and a beta of 1.47.

About Innovator IBD 50 ETF

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.